+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medical Marijuana Market - Global Forecast 2026-2032- Product Image
Medical Marijuana Market - Global Forecast 2026-2032- Product Image
Sale

Medical Marijuana Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5674852
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Medical Marijuana Market is projected to reach USD 18.70 Billion in 2026. It is expected to continue growing at a CAGR of 9.14%, reaching USD 31.60 Billion by 2032.

The medical marijuana market is moving from advocacy-led adoption to evidence-led healthcare integration. Demand is anchored by patients and clinicians seeking cannabinoid-based therapies for conditions where conventional options may be insufficient, including chemotherapy-induced nausea, multiple sclerosis spasticity, epilepsy syndromes treated with prescription cannabidiol, and chronic pain management under jurisdiction-specific rules.

Verified policy milestones continue to shape the sector. Canada legalized adult-use cannabis federally in 2018 while maintaining medical access; the U.S. Food and Drug Administration has approved cannabis-derived and synthetic cannabinoid medicines, including cannabidiol oral solution for specific seizure disorders and dronabinol and nabilone products for approved indications; and the United Nations Commission on Narcotic Drugs voted in 2020 to remove cannabis from Schedule IV of the 1961 Single Convention while keeping it internationally controlled. These developments support a more regulated medical cannabis ecosystem built around quality, traceability, clinical evidence, and patient safety.

Transformative Shifts in the Medical Cannabis Landscape

The medical marijuana landscape is being transformed by the convergence of regulatory modernization, pharmaceutical-grade manufacturing, and patient demand for standardized cannabinoid therapies. Countries that once relied on exceptional-access programs are increasingly building formal medical cannabis pathways, while established markets are tightening requirements around product testing, labeling accuracy, contamination control, and prescriber oversight.

A second shift is the separation of medical marijuana from general consumer cannabis. Healthcare systems, insurers, hospital formularies, and regulators are prioritizing products with defined cannabinoid profiles, reproducible dosing, and documented safety monitoring. As a result, operators that can demonstrate Good Manufacturing Practice alignment, pharmacovigilance discipline, and credible clinical data are better positioned than participants competing solely on flower volume or retail footprint.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is adding cumulative value across the medical marijuana value chain by improving evidence review, cultivation consistency, manufacturing quality, and patient support. AI-enabled literature mining can help research teams monitor cannabinoid studies, adverse-event signals, and drug-interaction evidence more efficiently, while machine learning models can support controlled-environment agriculture through climate optimization, pest detection, and yield forecasting.

In commercial and clinical operations, AI is most valuable when governed by validated data, human oversight, and privacy safeguards. Medical cannabis organizations are applying analytics to inventory planning, batch-release trends, patient-reported outcomes, and regulatory documentation. The strategic advantage is not replacing clinical judgment, but converting fragmented cultivation, dispensing, and real-world evidence data into auditable insights that improve compliance and therapeutic consistency.

Key Regional Insights: Global Medical Marijuana Demand

Asia-Pacific is characterized by selective legalization and strong pharmaceutical oversight, with Australia operating a regulated medical cannabis access system through prescription and special-access pathways, while several Asian jurisdictions maintain strict narcotics controls. North America remains the most mature regulated commercial region because Canada has federal medical and adult-use frameworks and the United States has broad state-level medical cannabis access despite continuing federal restrictions under the Controlled Substances Act.

Latin America is important as both a patient-access and cultivation region, with countries such as Brazil, Mexico, and Colombia shaping policy through health-agency approvals, court decisions, import pathways, and licensing models. Europe is advancing through prescription-based systems, with Germany representing a major reference point after expanding access and reforming cannabis law in 2024, while the United Kingdom, France, Italy, Spain, and other markets maintain more controlled medical channels.

The Middle East and Africa show uneven but strategically relevant development. Some Middle Eastern markets remain highly restrictive, while Israel has long-standing medical cannabis research and patient access experience. In Africa, Lesotho, South Africa, and selected jurisdictions have pursued medical cannabis cultivation, licensing, or patient access initiatives, although export compliance, domestic affordability, and regulatory capacity remain central constraints.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN remains one of the most restrictive regional blocs for cannabis, although Thailand’s policy opening created a notable test case for medical and wellness-related cannabis regulation before subsequent policy tightening discussions. The GCC is generally conservative because narcotics laws are strict across Gulf states, making compliant pharmaceutical cannabinoid products a more plausible pathway than broad dispensary-based models.

The European Union is a critical regulatory reference area because member states apply national medical cannabis laws within broader EU standards for medicines, quality systems, pharmacovigilance, and cross-border trade. BRICS markets show divergent profiles: China has industrial hemp activity but strict cannabis control, India has traditional cannabis-related regulatory complexity, Brazil is expanding health-agency governed access, Russia remains restrictive, and South Africa has developed medical and cultivation frameworks.

G7 markets concentrate much of the world’s regulated medical cannabis spending, clinical research capacity, and investor attention through the United States, Canada, Germany, the United Kingdom, France, Italy, and Japan’s tightly controlled pharmaceutical environment. NATO members overlap significantly with North American and European markets, where compliance, pharmaceutical supply chains, and security standards influence procurement, research collaborations, and cross-border investment.

Key Country Insights: Priority Medical Marijuana Markets

The United States is the largest opportunity by patient population and state-level program breadth, yet federal Schedule I status has historically constrained banking, interstate commerce, tax treatment, and research. Canada provides one of the clearest federally regulated benchmarks, while Mexico and Brazil continue to evolve through health-authority and court-driven access models that emphasize imports, prescriptions, and regulated products.

In Europe, the United Kingdom permits specialist-prescribed cannabis-based products, Germany is a central growth market due to statutory health insurance reimbursement pathways and recent legal reforms, France has moved cautiously through medical cannabis experimentation, Italy uses military and import channels, Spain relies heavily on a limited pharmaceutical and regional framework, and Russia remains highly restrictive. These differences make country-level regulatory diligence essential for market entry.

Across Asia-Pacific, China maintains strict cannabis controls while supporting industrial hemp in selected provinces, India’s opportunity is shaped by traditional use and narcotics regulation, Japan permits tightly controlled cannabinoid pharmaceutical pathways while restricting THC, Australia has one of the region’s more established medical cannabis access systems, and South Korea allows limited access to approved cannabis-based medicines under government oversight.

Actionable Recommendations for Medical Cannabis Leaders

Industry leaders should prioritize medical credibility over rapid assortment expansion. The most resilient strategies include validated quality systems, cannabinoid-profile consistency, stability data, contaminant testing, prescriber education, and pharmacovigilance. Organizations entering new countries should map narcotics law, medicine law, import requirements, advertising restrictions, and reimbursement rules before committing capital.

Executives should also invest in real-world evidence, AI-supported compliance analytics, and patient-support infrastructure that respects health-data privacy. Strategic partnerships with universities, contract research organizations, hospital networks, and GMP-certified manufacturers can improve evidence generation while reducing execution risk in a market where regulation, clinical trust, and supply reliability determine durable advantage.

Research Methodology

This executive summary is based on a secondary research methodology using verified public-domain sources, including national health agencies, medicines regulators, international drug-control policy references, peer-reviewed clinical literature, and official cannabis program documentation. The analysis emphasizes regulatory status, approved therapeutic uses, access pathways, quality requirements, and regional commercialization patterns.

Data interpretation follows a triangulation approach, comparing policy milestones, clinical evidence, and market-structure indicators across regions and country clusters. Claims are limited to documented developments and observable industry practices, with forward-looking implications framed as strategic considerations rather than unsupported forecasts.

Conclusion

Medical marijuana is becoming a more regulated, clinically scrutinized, and technology-enabled healthcare category. The strongest pathways are likely to favor organizations that can meet pharmaceutical expectations while navigating country-specific cannabis laws and patient-access models.

As regulators demand better evidence and patients seek consistent outcomes, the market’s center of gravity is shifting toward standardized cannabinoid therapeutics, compliant supply chains, and data-driven care models. Leaders that combine science, quality, and responsible commercialization will be best positioned in the global medical cannabis market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medical Marijuana Market, by Product Type
7.1. Introduction
7.2. Capsules
7.3. Concentrates
7.4. Edibles
7.4.1. Solid
7.4.2. Beverages
7.4.3. Powders & Mixes
7.5. Flower
7.6. Topicals
7.6.1. Creams & Lotions
7.6.2. Balms & Salves
7.6.3. Transdermal Patches
7.7. Extracts & Concentrates
7.7.1. Oils
7.7.2. Tinctures
7.7.3. . Resins & Waxes
8. Medical Marijuana Market, by Cultivation Type
8.1. Introduction
8.2. Greenhouse Cultivation
8.3. Indoor Cultivation
8.4. Outdoor Cultivation
9. Medical Marijuana Market, by Route of Administration
9.1. Introduction
9.2. Inhalation
9.3. Oral
9.4. Topical
10. Medical Marijuana Market, by Application
10.1. Introduction
10.2. Cancer
10.3. Chronic Pain
10.4. Neurological & Mental Health Disorders
10.4.1. Multiple sclerosis
10.4.2. Parkinson’s Disease
10.4.3. Anxiety & PTSD
10.4.4. Depression
10.5. Sleep Disorders
10.6. Gastrointestinal Disorders
11. Medical Marijuana Market, by Age Group
11.1. Introduction
11.2. Adult
11.3. Pediatric
11.4. Geriatric
12. Medical Marijuana Market, by Distribution Channel
12.1. Introduction
12.2. Offline
12.3. Online
13. Medical Marijuana Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Medical Marijuana Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Medical Marijuana Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Acreage Holdings Inc.
17.2. Ascend Wellness Holdings Inc.
17.3. Aurora Cannabis Inc.
17.4. Ayr Wellness Inc.
17.5. Botanix Pharmaceuticals Ltd.
17.6. Canopy Growth Corporation
17.7. Cantourage Group SE
17.8. Cresco Labs Inc.
17.9. Cronos Group Inc.
17.10. Curaleaf Holdings Inc.
17.11. Glass House Brands Inc.
17.12. Green Thumb Industries Inc.
17.13. GrowGeneration Corp
17.14. High Tide Inc.
17.15. Innovative Industrial Properties Inc
17.16. InterCure Ltd.
17.17. Jazz Pharmaceuticals plc
17.18. Jushi Holdings Inc.
17.19. MariMed Inc.
17.20. Organigram Holdings Inc.
17.21. Planet 13 Holdings Inc.
17.22. SNDL Inc.
17.23. TerrAscend Corp
17.24. Tilray Brands Inc.
17.25. Trulieve Cannabis Corp.
17.26. Verano Holdings Corp.
17.27. Village Farms International Inc.
List of Figures
FIGURE 1. GLOBAL MEDICAL MARIJUANA MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL MEDICAL MARIJUANA MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL MEDICAL MARIJUANA MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL MEDICAL MARIJUANA MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL MEDICAL MARIJUANA MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 15. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL MEDICAL MARIJUANA MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL MEDICAL MARIJUANA MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL MEDICAL MARIJUANA MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL MEDICAL MARIJUANA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CAPSULES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CAPSULES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CAPSULES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CONCENTRATES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CONCENTRATES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CONCENTRATES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL EDIBLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL EDIBLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL EDIBLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL SOLID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL SOLID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL SOLID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL BEVERAGES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL BEVERAGES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL BEVERAGES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL POWDERS & MIXES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL POWDERS & MIXES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL POWDERS & MIXES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL FLOWER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL FLOWER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL FLOWER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL TOPICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL TOPICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL TOPICALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CREAMS & LOTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL CREAMS & LOTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL CREAMS & LOTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL BALMS & SALVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL BALMS & SALVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL BALMS & SALVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL EXTRACTS & CONCENTRATES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL EXTRACTS & CONCENTRATES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL EXTRACTS & CONCENTRATES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL OILS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL OILS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL OILS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL TINCTURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL TINCTURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL TINCTURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL . RESINS & WAXES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL . RESINS & WAXES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL . RESINS & WAXES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL GREENHOUSE CULTIVATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL GREENHOUSE CULTIVATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL GREENHOUSE CULTIVATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL INDOOR CULTIVATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL INDOOR CULTIVATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL INDOOR CULTIVATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL OUTDOOR CULTIVATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL OUTDOOR CULTIVATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL OUTDOOR CULTIVATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL INHALATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL INHALATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL INHALATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CANCER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL CANCER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL CANCER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL CHRONIC PAIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CHRONIC PAIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL CHRONIC PAIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL NEUROLOGICAL & MENTAL HEALTH DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL NEUROLOGICAL & MENTAL HEALTH DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL NEUROLOGICAL & MENTAL HEALTH DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL MULTIPLE SCLEROSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL PARKINSON’S DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL PARKINSON’S DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL PARKINSON’S DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL ANXIETY & PTSD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL ANXIETY & PTSD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL ANXIETY & PTSD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL DEPRESSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL DEPRESSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL DEPRESSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL SLEEP DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL SLEEP DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL SLEEP DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL GASTROINTESTINAL DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 137. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 140. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 148. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 150. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 151. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 152. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 153. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 154. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 155. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 156. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 157. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 158. EUROPE MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 159. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 160. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 161. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 162. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 163. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 164. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 165. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 166. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 167. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 170. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 171. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 172. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 173. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 174. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 175. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 176. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 177. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 178. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 179. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 180. AFRICA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 181. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 183. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 184. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 185. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 186. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 187. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 188. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 189. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 190. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 191. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 192. ASEAN MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 193. GCC MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 194. GCC MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 195. GCC MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 196. GCC MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 197. GCC MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 198. GCC MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 199. GCC MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 200. GCC MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 201. GCC MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 202. GCC MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 203. GCC MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 215. BRICS MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 216. BRICS MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 217. BRICS MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 218. BRICS MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 219. BRICS MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 220. BRICS MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 221. BRICS MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 222. BRICS MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 223. BRICS MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 224. BRICS MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 225. BRICS MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 226. G7 MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 227. G7 MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 228. G7 MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 229. G7 MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 230. G7 MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 231. G7 MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 232. G7 MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 233. G7 MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 234. G7 MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 235. G7 MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 236. G7 MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 237. NATO MEDICAL MARIJUANA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 238. NATO MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 239. NATO MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 240. NATO MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 241. NATO MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 242. NATO MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 243. NATO MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 244. NATO MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 245. NATO MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 246. NATO MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 247. NATO MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 248. GLOBAL MEDICAL MARIJUANA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 249. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 250. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 251. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 252. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 253. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 254. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 255. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 256. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 257. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 258. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 259. UNITED STATES MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 260. CANADA MEDICAL MARIJUANA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 261. CANADA MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 262. CANADA MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 263. CANADA MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 264. CANADA MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 265. CANADA MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 266. CANADA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 267. CANADA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 268. CANADA MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 269. CANADA MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 270. CANADA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 271. MEXICO MEDICAL MARIJUANA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 272. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 273. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 274. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 275. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 276. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 277. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 278. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 279. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 280. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 281. MEXICO MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 282. BRAZIL MEDICAL MARIJUANA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 283. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 284. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 285. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 286. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 287. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 288. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 289. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 290. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 291. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 292. BRAZIL MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 293. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 294. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 295. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 296. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 297. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 298. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 299. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 300. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 301. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 302. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 303. UNITED KINGDOM MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 304. GERMANY MEDICAL MARIJUANA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 305. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 306. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 307. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 308. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 309. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 310. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 311. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 312. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 313. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 314. GERMANY MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 315. FRANCE MEDICAL MARIJUANA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 316. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 317. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 318. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 319. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 320. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 321. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 322. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 323. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 324. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 325. FRANCE MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 326. RUSSIA MEDICAL MARIJUANA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 327. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 328. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 329. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 330. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 331. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 332. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 333. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 334. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 335. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 336. RUSSIA MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 337. ITALY MEDICAL MARIJUANA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 338. ITALY MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 339. ITALY MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 340. ITALY MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 341. ITALY MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 342. ITALY MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 343. ITALY MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 344. ITALY MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 345. ITALY MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 346. ITALY MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 347. ITALY MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 348. SPAIN MEDICAL MARIJUANA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 349. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 350. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 351. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 352. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 353. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 354. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 355. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 356. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY NEUROLOGICAL & MENTAL HEALTH DISORDERS, 2017-2032 (USD MILLION)
TABLE 357. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 358. SPAIN MEDICAL MARIJUANA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 359. CHINA MEDICAL MARIJUANA MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 360. CHINA MEDICAL MARIJUANA MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 361. CHINA MEDICAL MARIJUANA MARKET SIZE, BY EDIBLES, 2017-2032 (USD MILLION)
TABLE 362. CHINA MEDICAL MARIJUANA MARKET SIZE, BY TOPICALS, 2017-2032 (USD MILLION)
TABLE 363. CHINA MEDICAL MARIJUANA MARKET SIZE, BY EXTRACTS & CONCENTRATES, 2017-2032 (USD MILLION)
TABLE 364. CHINA MEDICAL MARIJUANA MARKET SIZE, BY CULTIVATION TYPE, 2017-2032 (USD MILLION)
TABLE 365. CHINA MEDICAL MARIJUANA MARKET SIZE, BY ROUTE OF ADMINIS

Companies Mentioned

  • Acreage Holdings Inc.
  • Ascend Wellness Holdings Inc.
  • Aurora Cannabis Inc.
  • Ayr Wellness Inc.
  • Botanix Pharmaceuticals Ltd.
  • Canopy Growth Corporation
  • Cantourage Group SE
  • Cresco Labs Inc.
  • Cronos Group Inc.
  • Curaleaf Holdings Inc.
  • Glass House Brands Inc.
  • Green Thumb Industries Inc.
  • GrowGeneration Corp
  • High Tide Inc.
  • Innovative Industrial Properties Inc
  • InterCure Ltd.
  • Jazz Pharmaceuticals plc
  • Jushi Holdings Inc.
  • MariMed Inc.
  • Organigram Holdings Inc.
  • Planet 13 Holdings Inc.
  • SNDL Inc.
  • TerrAscend Corp
  • Tilray Brands Inc.
  • Trulieve Cannabis Corp.
  • Verano Holdings Corp.
  • Village Farms International Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 18.7 Billion
Forecasted Market Value ( USD ) by 2032 $ 31.6 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Legal Marijuana Market - Global Forecast 2026-2032 - Product Image

Legal Marijuana Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Marijuana Market - Global Forecast 2026-2032 - Product Image

Marijuana Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Medical Marijuana - Global Strategic Business Report - Product Image

Medical Marijuana - Global Strategic Business Report

  • Report
  • 154 Pages
  • Global
From
Marijuana Drying and Curing Equipment - Global Strategic Business Report - Product Image

Marijuana Drying and Curing Equipment - Global Strategic Business Report

  • Report
  • 95 Pages
  • Global
From
Medical Marijuana Market Report 2026 - Product Image

Medical Marijuana Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.